lobbying_activities: 2676022
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2676022 | 84e61d87-40ba-4c4c-86a1-8196a096712c | Q3 | HEALTH AND MEDICINE COUNSEL, LLC | 17818 | ORASURE TECHNOLOGIES INC | 2021 | third_quarter | HCR | Viral Hepatitis/HIV/AIDS Hep Action Plan Viral Hepatitis Testing Act Ebola Screening Substance Abuse testing CMS Reimbursement VA HCV testing policy CDC Elimination Initiative HHS AIDS Plan Oral Fluid Testing Guidelines | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS) | 10000 | 0 | 0 | 2021-10-04T09:27:05.450000-04:00 |